Geographic · Net Sales

China — Net Sales

Abbott China — Net Sales remained flat by 0.0% to $476.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.7%, from $528.25M to $476.75M. Over 4 years (FY 2021 to FY 2025), China — Net Sales shows a downward trend with a -5.5% CAGR.

Analysis

StatementSegment
First reportedQ1 2016
Last reportedQ4 2025Feb 20, 2026
Rolls up toTotal Revenue
Metric ID: abt_segment_china_net_sales

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$2.39B$2.13B$2.25B$2.11B$1.91B
YoY Change—-10.8%+5.6%-6.2%-9.7%
Range$1.91B – $2.39B
CAGR-5.5%
Avg YoY Growth-5.3%
Median YoY Growth-8.0%
Current Streak2 years decline

Frequently Asked Questions

What is Abbott's china — net sales?
Abbott (ABT) reported china — net sales of $476.75M in Q4 2025.
How has Abbott's china — net sales changed year-over-year?
Abbott's china — net sales decreased by 9.7% year-over-year, from $528.25M to $476.75M.
What is the long-term trend for Abbott's china — net sales?
Over 4 years (2021 to 2025), Abbott's china — net sales has grown at a -5.5% compound annual growth rate (CAGR), from $2.39B to $1.91B.